Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-26

Clinical Trial Update: A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 study evaluating TAS-102 plus nivolumab in patients with metastatic colorectal cancer; results were posted in Ju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lonsurf (trifluridine/tipiracil)
  • OPDIVO (nivolumab)

Snippet

Sponsor: Taiho Oncology, Inc. | Conditions: Refractory Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-07-26